Obese people infected with SARS-CoV-2 are on74% are more likely to need intensive care and 48% more likely to die than people of normal weight. In this regard, the fight against obesity, in the context of the ongoing COVID-19 pandemic, is becoming increasingly important today. American scientists have created long-acting antibodies BFKB8488A, the injection of which for 60 days speeds up metabolism and allows you to effectively reduce body weight.
The action of the revealed antibody, which mimics the hormone, which ensures an effective metabolism and increases energy expenditure, was tested in clinical trials on 60 volunteers.
The participants in the experiment were divided into twogroups. The first group of volunteers received one injection of the identified antibody, and the other received a placebo. Throughout the test, all patients received a balanced, identical diet. As a result, people who received the BFKB8488A injection lost 1.2 kg in body weight, while the volunteers who received the neutral drug lost only 0.28 kg.
It is noteworthy that the subjects who were injected with the new antibody lost interest in sweet foods, and after a week there was a decrease in the need for carbohydrates.